Hologic & the Hala - Rachel Nash Jerusalem Comprehensive Breast Clinic

The Walder Foundation Serving the Community with Excellence

MARLBOROUGH, Mass. (Feb 8-2019) Hologic Inc. a worldleading developer, manufacturer and supplier of innovative premium diagnostic technology for women’s health, is proud once again to partner with Hala- the Rachel Nash Jerusalem Comprehensive Breast Clinic, Israel’s leading breast cancer diagnostic center. The recent acquisition and installation of the new diagnostic systems at The Walder Foundation Ward, whom through their generous gift this acquisition was made possible; The 3Dimensions™ Tomosynthesis System which matches the unrivalled performance of our 3D Mammography™ exam together with the C-VIEW™ synthesized 2D imaging. In addition, the new acquisition and installation of the AFFIRM™ BREAST BIOPSY GUIDANCE SYSTEM, with the Brevera® Breast Biopsy System – a realtime imaging for instant verification and automated post-biopsy specimen handling- makes Hala Israel’s first clinic with the most advanced combined cutting edge technology available worldwide for the early detection of breast cancer.

Through this partnership and by introduction of these modalities, Hologic and Hala are saving thousands of lives every year. Hologic Inc. is dedicated to investing a high proportion of its resources to the development and deployment of innovative screening diagnostic and therapeutic technologies to meet the complex challenges of breast cancer.

Hala – the Rachel Nash Jerusalem Comprehensive Breast Clinic is an internationally acclaimed facility for the early diagnosis of breast cancer. Hala has gained a reputation for uncompromising medical care, coupled with the latest technological systems enabling its diagnostic treatment to be at the highest level available at this part of the world. Hologic is looking forward to collaborating with the Hala Clinic on future R&D modalities in breast health.